[1] Wang Y, Zhao X, Liu L, Soo YO, Pu Y, Pan Y, Wang Y, Zou X, Leung WH, Cai Y, Bai Q, Wu Y, Wang C, Pan X, Luo B, Wong KS; CICAS Study Group. Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China:the Chinese Intracranial Atherosclerosis (CICAS) Study[J]. Stroke, 2014, 45:663-669.
[2] Shinohara Y, Minematsu K, Amano T, Ohashi Y. Modified Rankin scale with expanded guidance scheme and interview questionnaire:interrater agreement and reproducibility of assessment[J]. Cerebrovasc Dis, 2006, 21:271-278.
[3] Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke[J]. Stroke, 2003, 34:109-137.
[4] Samuels OB, Joseph GJ, Lynn MJ, Smith HA, Chimowitz MI. A standardized method for measuring intracranial arterial stenosis[J]. AJNR Am J Neuroradiol, 2000, 21:643-646.
[5] Pandey AS, Thompson BG, Gemmete JJ, Chaudhary N. Cerebral collateral circulation:integral todefining clinical outcome in acute cerebral ischeinia[J]. World Neurosurg, 2012, 77:240-242.
[6] Gao F, Xu AD. Chinese guidelines for endovascular treatment of acute ischemic stroke[J]. Zhongguo Zu Zhong Za Zhi, 2015, 10:590-606.[高峰, 徐安定. 急性缺血性卒中血管内治疗中国指南2015[J]. 中国卒中杂志, 2015, 10:590-606.]
[7] Chen QT. Clinical neurology[M]. Beijing:Beijing Science and Technology Publishing, 2000.[陈清棠. 临床神经病学[M]. 北京:北京科学技术出版社, 2000.]
[8] Ma N, Mo DP, Gao F, Miao ZR. Endovascular recanalization for chronic symptomatic middle cerebral artery total occlusion[J]. J Neurointerv Surg, 2013, 5:e15.
[9] Aghaebrahim A, Jovin T, Jadhav AP, Noorian A, Gupta R, Nogueira RG. Endovascular recanalization of complete subacute to chronic atherosclerotic occlusions of intracranial arteries[J]. J Neurointerv Surg, 2014, 6:645-648.
[10] Zheng M, Song Y, Zhang J, Zhao E, Sun L, Yin H, Zhang J, Wang W, Han J. Endovascular recanalization of non-acute symptomatic middle cerebral artery total occlusion and its short-term outcomes[J]. Front Neurol, 2019, 10:484-489.
[11] Lau AY, Wong EH, Wong A, Mok VC, Leung TW, Wong KL. Significance of good collateral compensation in symptomatic intracranial atheroscIerosis[J]. Cerebrovasc Dis, 2012, 33:517-524.
[12] Tomsick TA, Yeatts SD, Liebeskind DS, Carrozzella J, Foster L, Goyal M, Kummer R, Hill MD, Demchuk AM, Jovin T, Yan B, Zaidat OO, Schonewille W, Engelter S, Martin R, Khatri P, Spilker J, Palesch YY, Broderick JP; IMS Ⅲ Investigators. Endovascular revascularization results in IMS Ⅲ:intracranial ICA and M1 occlusions[J]. J Neurointerv Surg, 2015, 7:795-802.
[13] Teeuwen K, Adriaenssens T, Van den Branden BJ, Henriques JP, Van der Schaaf RJ, Koolen JJ, Vermeersch PH, Bosschaert MA, Tijssen JG, Suttorp MJ. A randomized multicenter comparison of hybrid sirolimus-eluting stents with bioresorbable polymer versus everolimus-eluting stents with durable polymer in total coronary occlusion:rationale and design of the primary stenting of occluded native coronary arteries Ⅳ study[J]. Trials, 2012, 13:240.
[14] Zhang K, Zhao TY, Xue JY, Zhang L, Li TX. Recanalization of middle cerebral artery occlusion in non acute phase:a case report and literature review[J/CD]. Zhonghua Wei Zhong Zheng Yi Xue Za Zhi (Dian Zi Ban), 2016, 9:262-265.[张坤, 赵同源,薛绛宇, 张磊, 李天晓. 非急性期大脑中动脉闭塞血管腔内再通一例及文献复习[J/CD]. 中华危重症医学杂志(电子版), 2016, 9:262-265.] |